3.74
Precedente Chiudi:
$3.49
Aprire:
$3.49
Volume 24 ore:
420.65K
Relative Volume:
0.99
Capitalizzazione di mercato:
$320.07M
Reddito:
$351.37M
Utile/perdita netta:
$-174.01M
Rapporto P/E:
-1.8068
EPS:
-2.07
Flusso di cassa netto:
$-126.94M
1 W Prestazione:
+8.09%
1M Prestazione:
+10.65%
6M Prestazione:
+18.35%
1 anno Prestazione:
-2.35%
Atea Pharmaceuticals Inc Stock (AVIR) Company Profile
Nome
Atea Pharmaceuticals Inc
Settore
Industria
Telefono
857-204-8109
Indirizzo
225 FRANKLIN STREET, BOSTON
Confronta AVIR con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
AVIR
Atea Pharmaceuticals Inc
|
3.74 | 293.54M | 351.37M | -174.01M | -126.94M | -2.07 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Atea Pharmaceuticals Inc Stock (AVIR) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-08-13 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
2023-08-10 | Downgrade | JP Morgan | Neutral → Underweight |
2022-01-06 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
2021-11-18 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
2021-10-20 | Downgrade | JP Morgan | Overweight → Neutral |
2021-10-05 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2020-11-25 | Iniziato | Evercore ISI | Outperform |
2020-11-24 | Iniziato | JP Morgan | Overweight |
2020-11-24 | Iniziato | Morgan Stanley | Overweight |
2020-11-24 | Iniziato | William Blair | Outperform |
Mostra tutto
Atea Pharmaceuticals Inc Borsa (AVIR) Ultime notizie
What analysts say about Atea Pharmaceuticals Inc. stock outlookHigh-velocity gains - jammulinksnews.com
Will Atea Pharmaceuticals Inc. stock benefit from interest rate changesExceptional profit margins - jammulinksnews.com
What drives Atea Pharmaceuticals Inc. stock priceUnprecedented profit potential - Autocar Professional
What analysts say about Atea Pharmaceuticals Inc. stockFree High-Return Strategy Alerts - Autocar Professional
Atea Pharmaceuticals Insiders Placed Bullish Bets Worth US$5.40m - Yahoo.co
Atea Pharmaceuticals Inc. Stock Analysis and ForecastDynamic investment growth - jammulinksnews.com
Is Atea Pharmaceuticals Inc. a good long term investmentFree Investment Community - jammulinksnews.com
Why Atea Pharmaceuticals Inc. stock attracts strong analyst attentionFree Stock Selection with 300% Return - Newser
What makes Atea Pharmaceuticals Inc. stock price move sharplyFree Stock Portfolio Optimization - Newser
How Atea Pharmaceuticals Inc. stock performs during market volatilityFree Stock Movement Tracking - Newser
Atea Pharmaceuticals announces continued advancement of global Phase 3 HCV program - European AIDS Treatment Group
Atea Pharmaceuticals Announces IND Clearance of AT-527 for COVID-19 and $215 Million Financing - Bain Capital
New Hepatitis C Treatment Could Slash Therapy Time to 8 Weeks as Global Phase 3 Trial Advances - Stock Titan
Atea Pharmaceuticals Holds 2025 Annual Stockholders Meeting - TipRanks
Here's Why We're Not At All Concerned With Atea Pharmaceuticals' (NASDAQ:AVIR) Cash Burn Situation - Yahoo Finance
Bank of America Corp DE Boosts Stock Position in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World
Millennium Management LLC Invests $75,000 in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World
Squarepoint Ops LLC Buys 35,053 Shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Shares Sold by Two Sigma Investments LP - Defense World
Jane Street Group LLC Decreases Stock Holdings in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World
Public Employees Retirement System of Ohio Trims Stock Holdings in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World
Ameriprise Financial Inc. Sells 11,900 Shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World
ProShare Advisors LLC Buys 6,163 Shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World
Layoff Tracker: Keros Cuts 45% of Workforce Along With Pulmonary Hypertension Drug - BioSpace
BNP Paribas Financial Markets Buys New Shares in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World
Northern Trust Corp Boosts Holdings in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World
D. E. Shaw & Co. Inc. Purchases 62,505 Shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World
Wall Street Zen Upgrades Atea Pharmaceuticals (NASDAQ:AVIR) to “Hold” - Defense World
Price T Rowe Associates Inc. MD Purchases 3,882 Shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World
Atea Pharmaceuticals Inc Azioni (AVIR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):